Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The ...

The ministry of Health in Uganda has launched an extensive newborn screening initiative designed to tackle sickle cell ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living ...

One of the most critical complications Black women face is postpartum hemorrhage (PPH). Here's what you need to ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...